Among the interleukins with positive effects in the course of MS, we can include IL-4, IL-10, and IL-13, while those with negative effects include interleukin 1β (IL-1β), IL-6, IL-18, IL-12, and IL-23. This evidence concerns the gene IL23A and myeloid sarcoma.